Johnson Chemical Pharmaceutical Works Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
August 11, 2023 at 05:48 am
Share
Johnson Chemical Pharmaceutical Works Co., Ltd. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was TWD 155.21 million compared to TWD 116.56 million a year ago. Net income was TWD 22.52 million compared to TWD 14.35 million a year ago. Basic earnings per share from continuing operations was TWD 0.75 compared to TWD 0.48 a year ago. Diluted earnings per share from continuing operations was TWD 0.7 compared to TWD 0.48 a year ago.
For the six months, sales was TWD 303.96 million compared to TWD 226.96 million a year ago. Net income was TWD 44.89 million compared to TWD 27.06 million a year ago. Basic earnings per share from continuing operations was TWD 1.5 compared to TWD 0.9 a year ago. Diluted earnings per share from continuing operations was TWD 1.44 compared to TWD 0.9 a year ago.
Johnson Chemical Pharmaceutical Works Co., Ltd. is a Taiwan-based company principally engaged in the manufacture and distribution of western medicines and the related raw materials. The Company mainly provides solid dosage forms, including soft and hard capsules, sugar coated tablets, film-coated tablets, suppositories, powder, granules, tablets and others. The Companyâs products include central nervous system drugs, hormones and hormone function medicines, respiratory medicines, gastrointestinal drugs, vitamins and others. The Company mainly distributes its products in Taiwan market and the rest of Asia.